Showing results (81-90 of 207) with videos related to
Sort By:
Pageof 21
Pharmacological Reports : PR|March 28, 2020
Changes in PCSK9 and LDL cholesterol concentrations by everolimus treatment and their effects on polymorphisms in PCSK9 and mTORC1Shiori Sato, Yumiko Akamine, Hideaki Kagaya, et al.Hinyokika Kiyo. Acta Urologica Japonica|February 26, 2004
[A case of retroperitoneal extramedullary plasmacytoma]Mitsuru Saito, Norihiko Tsuchiya, Masahiro Iinuma, et al.Hinyokika Kiyo. Acta Urologica Japonica|October 16, 2007
Possible survival benefit of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin combination therapy (HD-MVAC) over conventional MVAC in metastatic urothelial carcinoma patientsTakamitsu Inoue, Takashi Obara, Mitsuru Saito, et al.Journal of Experimental Botany|January 9, 2009
A green fluorescent protein fused to rice prolamin forms protein body-like structures in transgenic riceYuhi Saito, Koichi Kishida, Kenji Takata, et al.Transplantation|October 27, 2004
Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipientsNorihiko Tsuchiya, Shigeru Satoh, Hitoshi Tada, et al.Hinyokika Kiyo. Acta Urologica Japonica|February 12, 2008
[A case of ruptured intra-renal aneurysm caused by renal allograft biopsy]Takamitsu Inoue, Shigeru Satoh, Mitsuru Saito, et al.International Journal of Clinical Oncology|April 20, 2007
Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomyYohei Horikawa, Teruaki Kumazawa, Shintaro Narita, et al.European Journal of Clinical Pharmacology|January 7, 2009
CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipientsShigeru Satoh, Mitsuru Saito, Takamitsu Inoue, et al.Hinyokika Kiyo. Acta Urologica Japonica|August 12, 2011
[Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin]Souhei Kanda, Takamitsu Inoue, Hiroshi Tsuruta, et al.Hinyokika Kiyo. Acta Urologica Japonica|April 28, 2005
[Active combination immunochemotherapy with interferon-alpha, interleukin-2 and gemcitabine for four patients with metastatic renal cell carcinoma]Takamitsu Inoue, Chikara Ohyama, Shingo Hatakeyama, et al.Pageof 21